Class action lawsuits
Apple, a multinational technology company, has been sued by investors for potential securities law violations related to the company's smart-devices and artificial intelligence (AI) business. The lawsuit, filed in the U.S. District Court for the Northern District of California, claims that Apple misrepresented the advanced AI-based features
Class action lawsuits
Sable Offshore Corp. (NYSE: SOC) has been the subject of a securities class action lawsuit filed on behalf of purchasers of the company's securities between May 19, 2025 and June 3, 2025, as well as those who purchased shares pursuant to the company's secondary public offering
Class action lawsuits
Replimune Group, Inc.'s (NASDAQ: REPL) securities class action lawsuit alleges that the company made false and misleading statements about the prospects of its IGNYTE trial, which resulted in the U.S. Food and Drug Administration ("FDA") deeming the trial inadequate and not well-controlled. The lawsuit claims
Class action lawsuits
Investors in Rocket Pharmaceuticals who suffered significant losses after the company's Phase 2 trial for Danon disease was placed on clinical hold by the FDA are now being encouraged to seek compensation. The company's shares plummeted over 60% in a single day after the announcement, wiping
Class action lawsuits
Purchasers of Rocket Pharmaceuticals securities may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement, thanks to a class action lawsuit filed against the company. The lawsuit alleges that defendants made false and/or misleading statements and/or failed to disclose key
Class action lawsuits
Class action lawsuit filed against Petco Health and Wellness Company, Inc. seeks to recover losses of shareholders who were allegedly affected by securities fraud between January 14, 2021 and June 5, 2025. The lawsuit claims that Petco's business model was unsustainable and that the company's public
Class action lawsuits
A lawsuit has been filed against Centene Corporation (NYSE: CNC) and certain senior executives for potential violations of the federal securities laws. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Centene securities. The case
Class action lawsuits
Alto Neuroscience, a biotech company specializing in brain health, is embroiled in a class action lawsuit regarding its initial public offering and subsequent stock sales. The lawsuit alleges that the company made false and misleading statements about its products, specifically ALTO-100, a treatment for major depressive disorder. The case is
Class action lawsuits
A class action lawsuit has been filed on behalf of investors who purchased Sable Offshore Corp. (NYSE: SOC) securities between May 19, 2025, and June 3, 2025, or from the May 21, 2025, secondary public offering (SPO). The lawsuit alleges that defendants made materially false and/or misleading statements about
Class action lawsuits
Pomerantz LLP has announced a class action lawsuit against Hims & Hers Health, Inc. ("Hims & Hers") due to allegations of securities fraud and other unlawful business practices. The law firm is seeking to appoint a lead plaintiff for the class of investors who purchased or acquired Hims
Class action lawsuits
Investors in Novo Nordisk A/S ("Novo") have been notified of a class action securities lawsuit, which seeks to recover losses on behalf of investors who were allegedly affected by securities fraud between May 7, 2025 and July 28, 2025. The lawsuit claims that Novo's management
Class action lawsuits
A class action securities lawsuit was filed against Sarepta Therapeutics, Inc., alleging that the company made false statements and concealed the safety risks associated with its ELEVIDYS prescription gene therapy for Duchenne. The lawsuit seeks to recover losses of shareholders who were adversely affected between June 22, 2023, and June
